Stem cells injected into spine: hope for paralysis?
NCT ID NCT06976229
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests a new treatment called XS228, made from special stem cells that can become nerve cells. The goal is to see if injecting these cells into the spine is safe and tolerable for people who had a spinal cord injury 2 to 8 weeks ago. Up to 12 adults with injuries between the neck and lower back will take part. The study focuses on safety first, but will also check if the treatment helps improve movement or nerve function.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLINICAL TRIALS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Third Affiliated Hospital of Sun Yat-sen University
RECRUITINGGuangzhou, Guangdong, 510630, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a 'Smart Bridge' in the spine help paralyzed patients walk again?
- Spinal zaps may steady blood pressure in spinal cord injury
- Can a simple pill stabilize blood pressure after spinal cord injury?
- Can breathing power boost balance and Well-Being in paralympic athletes?
- Spinal implant + robot rehab: a new hope for walking after injury?
- Can a robotic suit plus spinal stimulation help paralyzed individuals walk again?